Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sihogayonggolmoryeo-tang is a traditional Korean herbal medicine (Hanbang) formulation derived from the classic medical text *Shanghan Lun*. It is primarily utilized to treat neuropsychiatric symptoms associated with **hwa-byung**, a Korean culture-bound syndrome characterized by suppressed anger, anxiety, and depression. The formulation typically consists of several herbal and mineral components, including *Bupleurum falcatum*, *Scutellaria baicalensis*, *Fossilia Mastodi* (dragon bone), and *Ostrea gigas* (oyster shell). It is believed to exert its therapeutic effects by modulating the neuroendocrine system, specifically the hypothalamic-pituitary-adrenal (HPA) axis and GABAergic neurotransmission, to provide anxiolytic and sedative benefits. The Korea Health Industry Development Institute (KHIDI) has supported phase 4 clinical trials to evaluate its efficacy in managing anxiety within the context of hwa-byung.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sihogayonggolmoryeo-tang.